181 related articles for article (PubMed ID: 16971493)
21. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
[TBL] [Abstract][Full Text] [Related]
22. The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts.
Diller M; Frommer K; Dankbar B; Tarner I; Hülser ML; Tsiklauri L; Hasseli R; Sauerbier M; Pap T; Rehart S; Müller-Ladner U; Neumann E
Arthritis Res Ther; 2019 Jun; 21(1):144. PubMed ID: 31182152
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of genistein ability to modulate CTGF mRNA/protein expression, genes expression of TGFβ isoforms and expression of selected genes regulating cell cycle in keloid fibroblasts in vitro.
Jurzak M; Adamczyk K; Antończak P; Garncarczyk A; Kuśmierz D; Latocha M
Acta Pol Pharm; 2014; 71(6):972-86. PubMed ID: 25745770
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
[TBL] [Abstract][Full Text] [Related]
26. Hepatoma-derived growth factor and its role in keloid pathogenesis.
Ooi BN; Mukhopadhyay A; Masilamani J; Do DV; Lim CP; Cao XM; Lim IJ; Mao L; Ren HN; Nakamura H; Phan TT
J Cell Mol Med; 2010 Jun; 14(6A):1328-37. PubMed ID: 19432814
[TBL] [Abstract][Full Text] [Related]
27. Deep and superficial keloid fibroblasts contribute differentially to tissue phenotype in a novel in vivo model of keloid scar.
Supp DM; Hahn JM; Glaser K; McFarland KL; Boyce ST
Plast Reconstr Surg; 2012 Jun; 129(6):1259-1271. PubMed ID: 22634643
[TBL] [Abstract][Full Text] [Related]
28. Role of activin-A in cigarette smoke-induced inflammation and COPD.
Verhamme FM; Bracke KR; Amatngalim GD; Verleden GM; Van Pottelberge GR; Hiemstra PS; Joos GF; Brusselle GG
Eur Respir J; 2014 Apr; 43(4):1028-41. PubMed ID: 24232707
[TBL] [Abstract][Full Text] [Related]
29. The activin binding proteins follistatin and follistatin-related protein are differentially regulated in vitro and during cutaneous wound repair.
Wankell M; Kaesler S; Zhang YQ; Florence C; Werner S; Duan R
J Endocrinol; 2001 Dec; 171(3):385-95. PubMed ID: 11739004
[TBL] [Abstract][Full Text] [Related]
30. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization.
Eijken M; Swagemakers S; Koedam M; Steenbergen C; Derkx P; Uitterlinden AG; van der Spek PJ; Visser JA; de Jong FH; Pols HA; van Leeuwen JP
FASEB J; 2007 Sep; 21(11):2949-60. PubMed ID: 17449718
[TBL] [Abstract][Full Text] [Related]
31. Reconstructed human keloid models show heterogeneity within keloid scars.
Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495
[TBL] [Abstract][Full Text] [Related]
32. The activin-follistatin system and in vitro early follicle development in goats.
Silva JR; Tharasanit T; Taverne MA; van der Weijden GC; Santos RR; Figueiredo JR; van den Hurk R
J Endocrinol; 2006 Apr; 189(1):113-25. PubMed ID: 16614386
[TBL] [Abstract][Full Text] [Related]
33. Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin.
Nakamura M; Matzuk MM; Gerstmayer B; Bosio A; Lauster R; Miyachi Y; Werner S; Paus R
FASEB J; 2003 Mar; 17(3):497-9. PubMed ID: 12514121
[TBL] [Abstract][Full Text] [Related]
34. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
36. Activin and follistatin in rat mammary gland.
Bussmann UA; Lanuza GM; Bussmann LE
Mol Cell Endocrinol; 2004 Jun; 221(1-2):9-19. PubMed ID: 15223128
[TBL] [Abstract][Full Text] [Related]
37. The Aldo-Keto Reductase AKR1B10 Is Up-Regulated in Keloid Epidermis, Implicating Retinoic Acid Pathway Dysregulation in the Pathogenesis of Keloid Disease.
Jumper N; Hodgkinson T; Arscott G; Har-Shai Y; Paus R; Bayat A
J Invest Dermatol; 2016 Jul; 136(7):1500-1512. PubMed ID: 27025872
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of cartilage oligomeric matrix protein as a novel pathogenic factor in keloids.
Inui S; Shono F; Nakajima T; Hosokawa K; Itami S
Am J Pathol; 2011 Oct; 179(4):1951-60. PubMed ID: 21872564
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring.
Yu H; Bock O; Bayat A; Ferguson MW; Mrowietz U
J Plast Reconstr Aesthet Surg; 2006; 59(3):221-9. PubMed ID: 16676428
[TBL] [Abstract][Full Text] [Related]
40. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.
Liang CJ; Yen YH; Hung LY; Wang SH; Pu CM; Chien HF; Tsai JS; Lee CW; Yen FL; Chen YL
Biochem Pharmacol; 2013 Jun; 85(11):1594-602. PubMed ID: 23500539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
